Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
---|---|---|---|---|
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
US5663159 | GILEAD | Prodrugs of phosphonates |
Sep, 2014
(9 years ago) | |
US6451340 | GILEAD | Nucleotide analog compositions |
Jul, 2018
(5 years ago) |
Market Authorisation Date: 20 September, 2002
Treatment: Therapy in chronic hepatitis b virus infection
Dosage: TABLET;ORAL